CURR MED CHEM 润色咨询

CURRENT MEDICINAL CHEMISTRY

出版年份：1994 年文章数：5295 投稿命中率： 开通期刊会员，数据随心看

出版周期：Biweekly 自引率：1.8% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=491182, encodeId=2aac491182a4, content=我们是杂志约稿的，6月20日投的，目前仍在under review., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=646, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=caf447473, createdName=zyhwxr, createdTime=Thu Oct 25 11:22:00 CST 2012, time=2012-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491045, encodeId=ea63491045df, content=楼上的是你的实验结果好吧。 <br> 这个杂志审稿很慢啊，拒稿还不给什么理由。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=477, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6dd769880, createdName=kaile1234, createdTime=Wed Oct 17 07:58:00 CST 2012, time=2012-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=821557, encodeId=babe82155eba, content=还行吧，一般的期刊！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f225414024, createdName=ms6336778790072332, createdTime=Thu Sep 13 19:09:00 CST 2012, time=2012-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817616, encodeId=f4d181e61682, content=if=4.63 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14215414107, createdName=ms7574356931796630, createdTime=Wed Jan 04 17:27:00 CST 2012, time=2012-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814863, encodeId=612f81486370, content=很好的杂志，值得看看 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7f15414091, createdName=ms9821035889741998, createdTime=Tue Jun 28 13:39:00 CST 2011, time=2011-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=475435, encodeId=b1014e543582, content=审稿速度:3.0 | 投稿命中率:20.0<br>经验分享：Current Medicinal Chemistry, (Impact factor 4.90) is the leading review journal in its field., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=578, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8d1520448, createdName=different, createdTime=Thu May 26 16:44:00 CST 2011, time=2011-05-26, status=1, ipAttribution=)]
    2012-10-25 zyhwxr

    我们是杂志约稿的，6月20日投的，目前仍在under review.

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=491182, encodeId=2aac491182a4, content=我们是杂志约稿的，6月20日投的，目前仍在under review., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=646, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=caf447473, createdName=zyhwxr, createdTime=Thu Oct 25 11:22:00 CST 2012, time=2012-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491045, encodeId=ea63491045df, content=楼上的是你的实验结果好吧。 <br> 这个杂志审稿很慢啊，拒稿还不给什么理由。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=477, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6dd769880, createdName=kaile1234, createdTime=Wed Oct 17 07:58:00 CST 2012, time=2012-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=821557, encodeId=babe82155eba, content=还行吧，一般的期刊！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f225414024, createdName=ms6336778790072332, createdTime=Thu Sep 13 19:09:00 CST 2012, time=2012-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817616, encodeId=f4d181e61682, content=if=4.63 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14215414107, createdName=ms7574356931796630, createdTime=Wed Jan 04 17:27:00 CST 2012, time=2012-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814863, encodeId=612f81486370, content=很好的杂志，值得看看 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7f15414091, createdName=ms9821035889741998, createdTime=Tue Jun 28 13:39:00 CST 2011, time=2011-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=475435, encodeId=b1014e543582, content=审稿速度:3.0 | 投稿命中率:20.0<br>经验分享：Current Medicinal Chemistry, (Impact factor 4.90) is the leading review journal in its field., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=578, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8d1520448, createdName=different, createdTime=Thu May 26 16:44:00 CST 2011, time=2011-05-26, status=1, ipAttribution=)]
    2012-10-17 kaile1234

    楼上的是你的实验结果好吧。
    这个杂志审稿很慢啊，拒稿还不给什么理由。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=491182, encodeId=2aac491182a4, content=我们是杂志约稿的，6月20日投的，目前仍在under review., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=646, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=caf447473, createdName=zyhwxr, createdTime=Thu Oct 25 11:22:00 CST 2012, time=2012-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491045, encodeId=ea63491045df, content=楼上的是你的实验结果好吧。 <br> 这个杂志审稿很慢啊，拒稿还不给什么理由。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=477, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6dd769880, createdName=kaile1234, createdTime=Wed Oct 17 07:58:00 CST 2012, time=2012-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=821557, encodeId=babe82155eba, content=还行吧，一般的期刊！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f225414024, createdName=ms6336778790072332, createdTime=Thu Sep 13 19:09:00 CST 2012, time=2012-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817616, encodeId=f4d181e61682, content=if=4.63 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14215414107, createdName=ms7574356931796630, createdTime=Wed Jan 04 17:27:00 CST 2012, time=2012-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814863, encodeId=612f81486370, content=很好的杂志，值得看看 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7f15414091, createdName=ms9821035889741998, createdTime=Tue Jun 28 13:39:00 CST 2011, time=2011-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=475435, encodeId=b1014e543582, content=审稿速度:3.0 | 投稿命中率:20.0<br>经验分享：Current Medicinal Chemistry, (Impact factor 4.90) is the leading review journal in its field., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=578, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8d1520448, createdName=different, createdTime=Thu May 26 16:44:00 CST 2011, time=2011-05-26, status=1, ipAttribution=)]
    2012-09-13 ms6336778790072332

    还行吧，一般的期刊！

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=491182, encodeId=2aac491182a4, content=我们是杂志约稿的，6月20日投的，目前仍在under review., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=646, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=caf447473, createdName=zyhwxr, createdTime=Thu Oct 25 11:22:00 CST 2012, time=2012-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491045, encodeId=ea63491045df, content=楼上的是你的实验结果好吧。 <br> 这个杂志审稿很慢啊，拒稿还不给什么理由。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=477, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6dd769880, createdName=kaile1234, createdTime=Wed Oct 17 07:58:00 CST 2012, time=2012-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=821557, encodeId=babe82155eba, content=还行吧，一般的期刊！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f225414024, createdName=ms6336778790072332, createdTime=Thu Sep 13 19:09:00 CST 2012, time=2012-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817616, encodeId=f4d181e61682, content=if=4.63 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14215414107, createdName=ms7574356931796630, createdTime=Wed Jan 04 17:27:00 CST 2012, time=2012-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814863, encodeId=612f81486370, content=很好的杂志，值得看看 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7f15414091, createdName=ms9821035889741998, createdTime=Tue Jun 28 13:39:00 CST 2011, time=2011-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=475435, encodeId=b1014e543582, content=审稿速度:3.0 | 投稿命中率:20.0<br>经验分享：Current Medicinal Chemistry, (Impact factor 4.90) is the leading review journal in its field., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=578, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8d1520448, createdName=different, createdTime=Thu May 26 16:44:00 CST 2011, time=2011-05-26, status=1, ipAttribution=)]
    2012-01-04 ms7574356931796630

    if=4.63

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=491182, encodeId=2aac491182a4, content=我们是杂志约稿的，6月20日投的，目前仍在under review., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=646, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=caf447473, createdName=zyhwxr, createdTime=Thu Oct 25 11:22:00 CST 2012, time=2012-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491045, encodeId=ea63491045df, content=楼上的是你的实验结果好吧。 <br> 这个杂志审稿很慢啊，拒稿还不给什么理由。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=477, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6dd769880, createdName=kaile1234, createdTime=Wed Oct 17 07:58:00 CST 2012, time=2012-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=821557, encodeId=babe82155eba, content=还行吧，一般的期刊！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f225414024, createdName=ms6336778790072332, createdTime=Thu Sep 13 19:09:00 CST 2012, time=2012-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817616, encodeId=f4d181e61682, content=if=4.63 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14215414107, createdName=ms7574356931796630, createdTime=Wed Jan 04 17:27:00 CST 2012, time=2012-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814863, encodeId=612f81486370, content=很好的杂志，值得看看 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7f15414091, createdName=ms9821035889741998, createdTime=Tue Jun 28 13:39:00 CST 2011, time=2011-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=475435, encodeId=b1014e543582, content=审稿速度:3.0 | 投稿命中率:20.0<br>经验分享：Current Medicinal Chemistry, (Impact factor 4.90) is the leading review journal in its field., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=578, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8d1520448, createdName=different, createdTime=Thu May 26 16:44:00 CST 2011, time=2011-05-26, status=1, ipAttribution=)]
    2011-06-28 ms9821035889741998

    很好的杂志，值得看看

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=491182, encodeId=2aac491182a4, content=我们是杂志约稿的，6月20日投的，目前仍在under review., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=646, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=caf447473, createdName=zyhwxr, createdTime=Thu Oct 25 11:22:00 CST 2012, time=2012-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491045, encodeId=ea63491045df, content=楼上的是你的实验结果好吧。 <br> 这个杂志审稿很慢啊，拒稿还不给什么理由。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=477, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6dd769880, createdName=kaile1234, createdTime=Wed Oct 17 07:58:00 CST 2012, time=2012-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=821557, encodeId=babe82155eba, content=还行吧，一般的期刊！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f225414024, createdName=ms6336778790072332, createdTime=Thu Sep 13 19:09:00 CST 2012, time=2012-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817616, encodeId=f4d181e61682, content=if=4.63 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14215414107, createdName=ms7574356931796630, createdTime=Wed Jan 04 17:27:00 CST 2012, time=2012-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814863, encodeId=612f81486370, content=很好的杂志，值得看看 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7f15414091, createdName=ms9821035889741998, createdTime=Tue Jun 28 13:39:00 CST 2011, time=2011-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=475435, encodeId=b1014e543582, content=审稿速度:3.0 | 投稿命中率:20.0<br>经验分享：Current Medicinal Chemistry, (Impact factor 4.90) is the leading review journal in its field., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=578, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8d1520448, createdName=different, createdTime=Thu May 26 16:44:00 CST 2011, time=2011-05-26, status=1, ipAttribution=)]
    2011-05-26 different

    审稿速度:3.0 | 投稿命中率:20.0
    经验分享：Current Medicinal Chemistry, (Impact factor 4.90) is the leading review journal in its field.

    0

共25条页码: 2/3页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分